Development of federally mandated risk evaluation and mitigation strategies (REMS) for transmucosal immediate-release fentanyl products.

Authors :: Pergolizzi JV
Gharibo CG
Gudin JA
Nalamachu SR
Source :: Pain practice : the official journal of World Institute of Pain [Pain Pract] 2013 Apr; Vol. 13 (4), pp. 259-63. Date of Electronic Publication: 2013 Mar 06.
Publication Year :: 2013

Subjects :: Administration, Mucosal
Humans
United States
Analgesics, Opioid administration & dosage
Fentanyl administration & dosage
Pain drug therapy
Pharmacovigilance
Risk Management methods

Full Text Access

Tools